![Chlamydia Infection Chlamydia](https://cpd.sutterhealth.org/sites/default/files/styles/course_image/public/course/2024-06/6829956633_efc159ff63_z_2.jpg?itok=D4XPD9GL)
0415_PAMF_ Improving Chlamydia Screening Grand Rounds_EM
Description:
Sexually active people can get chlamydia, a common, treatable, sexually transmitted disease (STD). There is a gap in chlamydia screening rates in females ages 16 years and older in our general pediatric clinic sites which can lead to under diagnosis of infections in affected females, of whom >84% are estimated to be asymptomatic. Females with untreated infections are at risk for pelvic inflammatory disease, ectopic pregnancy, increased risk of HIV, and infertility. This activity will address chlamydia screening rates in females ages 16 and older in general pediatric clinic sites - a metric that PAMF has been underperforming according to the quality dashboard. PAMF has instituted an opt-out screening across multiple general pediatric clinic sites in an attempt to increase the chlamydia screening rates. The goal is to increase the chlamydia screening rate in females ages 16 and older in Palo Alto Medical Foundation general pediatric clinic sites by 5% in 2024. PAMF will use the outcome measure of chlamydia screening rate, process measure of the number of patients who postpone or opt-out of screening, and balance measure of provider satisfaction to inform the quality improvement process. Completion criteria includes 12 months of data collection and process improvement with an emphasis on outcome measures of improving chlamydia screening rates.
Target Audience
Nurse Practitioner (NP)
Nurse, Registered (RN)
Physicians (MD or DO)
Physician Assistant (PA)
Learning Objectives
After this activity, learners should be able to:
1. Review the current PAMF data on chlamydia screening rate in females aged 16+.
2. Design personal practice strategy, documented in the Commitment to Change, to achieve the project goals:
3. Demonstrate a 5% increase of chlamydia screening rates of females aged 16 years and older at general PAMF pediatric clinic sites by 5% in 2024.
4. Prioritize achieving an <50% rate of patients who postpone or opt-out of chlamydia screening.
5. Participate in a survey of participating pediatricians for provider satisfaction with the screening process including qualitative feedback in order to limit the potentially negative impact of chlamydia screening on provider satisfaction and to inform PDSA cycles and real-time change in the screening process.
Assembly Bills 1195 & 241- Culturally Appropriate Care which is Free of Implicit Biases:
Learners are strongly encouraged to engage in self-directed learning related to the impact of implicit biases in this clinical area via the references provided below:
1. Learner ER, Powers KA, Torrone EA, Pence BW, Fine JP, Miller WC. The Influence of Screening, Misclassification, and Reporting Biases on Reported Chlamydia Case Rates Among Young Women in the United States, 2000 Through 2017. Sex Transm Dis. 2020 Jun;47(6):369-375. doi: 10.1097/OLQ.0000000000001157. PMID: 32149958; PMCID: PMC8711091.
2. Park IU, Amey A, Creegan L, Barandas A, Bauer HM. Retesting for repeat chlamydial infection: family planning provider knowledge, attitudes, and practices. J Womens Health (Larchmt). 2010 Jun;19(6):1139-44. doi: 10.1089/jwh.2009.1648. PMID: 20482236.
Disclosure of Financial or In-Kind Commercial Support & Conflict of Interest
Sarina Behera receives consultant fees from Brightheart related to AI ultrasound detection of fetal congenital heart disease. This ineligible financial relationship was deemed not relevant to the topic of this activity therefore no migration was required.
No one else involved in the planning or presentation of this educational activity have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No financial or in-kind commercial support was received to produce or promote this educational activity.
– Provider Designee/Verification: Kerri Maya, MSL, RN
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
Credit Designation Statement
Sutter Health designates this this LIVE activity for a maximum of 1.00 AMA PRA Category 1 Credits™ for physicians and 1.00 continuing professional development contact hours for nurses.
Note to Other Disciplines: AMA PRA Category 1 Credits HOURS™ Continuing Medical Education is acceptable for meeting the continuing education requirements for Pharmacists, Physician Assistants, Psychologists, Registered Nurses, and Respiratory Care Practitioners. For other disciplines, please check with the regulatory board for your discipline to confirm what type of credits meet the continuing education requirements. Continuing education hours for nurses accredited by ANCC, via Joint Accreditation.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Sutter Health designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™ for physicians. Learners should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit™ Hour(s)
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Sutter Health certifies this Enduring activity was designated for a maximum of 1.00 AMA PRA Category 1 Credit™ Hour(s). Non-physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 ANCC
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This course/program has been awarded 1.00 ANCC contact hour(s). Sutter Health is accredited provider of nursing continuing professional development. Learners should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 CA BRN
This activity is approved for 1.00 contact hour(s) by Sutter Health, which is an approved provider by the California Board of Registered Nursing. (Provider Number 17182). Learners should claim only the credit commensurate with the extent of their participation in the activity.